Cytochrome P-450 CYP1A2 Inhibitors (weak)
DBCAT002870Pharmacologic class
A DrugBank category of 25 drugs. 22 of them are approved.
- Also known as
- CYP1A2 Inhibitors (weak) · Weak CYP1A2 inhibitors
- Drugs
- Allopurinol
- Anagrelide
- Cariprazine
- Cimetidine
- Citalopram
- Clascoterone
- Conjugated estrogens
- Estradiol
- Estradiol acetate
- Estradiol benzoate
- Estradiol dienanthate
- Estradiol valerate
- Ethambutol
- Famotidine
- Genistein
- Mefenamic acid
- Nevirapine
- Opicapone
- Pipemidic acid
- Quercetin
- Rucaparib
- Tirbanibulin
- Tocainide
- Trovafloxacin
- Viloxazine
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP1A2 Inhibitors (weak) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account